Pulse Biosciences
PLSE
57 hedge funds and large institutions have $54.1M invested in Pulse Biosciences in 2024 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 25 increasing their positions, 16 reducing their positions, and 12 closing their positions.
61% more call options, than puts
Call options by funds: $2.15M | Put options by funds: $1.33M
56% more repeat investments, than reductions
Existing positions increased: 25 | Existing positions reduced: 16
30% more capital invested
Capital invested by funds: $41.5M → $54.1M (+$12.5M)
0.08% more ownership
Funds ownership: 8.67% → 8.75% (+0.08%)
8% less funds holding
Funds holding: 62 → 57 (-5)
33% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 12
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$961K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$548K |
| 3 |
State Street
Boston,
Massachusetts
|
+$395K |
| 4 |
N
Nuveen
Charlotte,
North Carolina
|
+$320K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$311K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$509K |
| 2 |
GAM
Griffin Asset Management
New York
|
-$402K |
| 3 |
SAG
Spotlight Asset Group
Oakbrook Terrace,
Illinois
|
-$300K |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$288K |
| 5 |
Simplex Trading
Chicago,
Illinois
|
-$283K |
PLSE Hedge Fund Activity: Q2 2024 in Review
57 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Pulse Biosciences (PLSE) for Q2 2024, worth a combined $54.1M — up 30% from $41.5M a quarter earlier.
Sellers outnumbered buyers: 12 funds closed out of PLSE and 8 opened new positions — a net loss of 4 holders — while 16 trimmed existing stakes and 25 added.
The largest buyer was BlackRock, adding an estimated $961K. The largest seller was Citadel Advisors, exiting entirely with an estimated $509K sold.
- 57 institutional investors held Pulse Biosciences (PLSE) as of Q2 2024, down from 62 in Q1 2024.
- Funds reported $54.1M of Pulse Biosciences stock for Q2 2024, up 30% quarter-over-quarter.
- 8 funds opened new Pulse Biosciences positions in Q2 2024 and 12 closed out, a net change of -4 holders.
- The largest Pulse Biosciences buyer in Q2 2024 was BlackRock, an estimated $961K added.
- The largest Pulse Biosciences seller in Q2 2024 was Citadel Advisors, an estimated $509K sold.
Based on aggregated 13F filings for Q2 2024.